Catalyst Pharmaceuticals (CN2.MU) Q2 2026 Earnings

11MayConfirmed
Q2 2026
0.4
0.41
0.42
0.42

Details

Expected EPS
0.40327025
Actual EPS
0.424495
Surprise EPS
0.02
Surprise Percent
+5.26%

Description

Catalyst Pharmaceuticals (CN2.MU) has reported earnings of 0.424495 per share for Q2 2026.

0 Comments

Share your thoughts